Manuka honey exhibits significant anti-influenza viral activity, inhibiting replication with virucidal effects. Combining manuka honey with existing drugs enhances their efficacy, suggesting its medicinal potential.
Network Pharmacology Antiviral Honey Influenza
This study aimed to address the urgent need for novel anti-influenza drugs by evaluating the anti-viral activity of honey, focusing on manuka honey. Antiviral activities were assessed using MDCK cells, revealing that manuka honey efficiently inhibited influenza virus replication with an IC50 of 3.6 ± 1.2 mg/mL and a CC50 of 82.3 ± 2.2 mg/mL, resulting in a selective index of 22.9. Virucidal effects were identified as the underlying mechanism. Furthermore, combining manuka honey with zanamivir or oseltamivir significantly enhanced their efficacy, showcasing the potential medicinal value of honey, particularly manuka honey, against the influenza virus.
The study underscores the potent inhibitory activity of honey, especially manuka honey, against influenza viruses, offering promising medicinal implications. The observed virucidal effects and the synergistic enhancement of known anti-influenza drugs highlight the multifaceted potential of honey in combating influenza infections. Further exploration of the specific mechanisms underlying these effects could contribute to the development of effective anti-influenza therapies.
View Article